Patent · US Active

Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity

US11046773B2 · kind B2 · utility

0Cited by

1References

16Claims

0Family size

Assignee

Ablynx N.V. · BE

Inventors

Hugo Soares · Rocky Hill, US
Dominique Schols · Herent, BE
Peter Vanlandschoot · Bellem, BE
Philippe Van Rompaey · Melle, BE
Catelijne Stortelers · Evergem, BE

Key dates

Filing date	Mar 7, 2019
Grant date	Jun 29, 2021
Priority date	—
Expiry date	Mar 7, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to bispecific polypeptides that are directed against the cellular receptor CD4 as well as a cellular co-receptor for HIV. Said polypeptides may be used to prevent human cell entry of HIV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.